Product Images Isosorbide Dinitrate And Hydralazine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Isosorbide Dinitrate And Hydralazine Hydrochloride NDC 50742-246 by Ingenus Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a figure depicting a Kaplan-Meier plot for time to first hospitalization for heart failure in black patients with data from the A-HeFT study. The plot shows a 39% risk reduction in first hospitalization for heart failure for patients taking BiDil compared to placebo. The X-axis shows time in days, and the Y-axis shows the percentage of patients without hospitalization. The legend indicates that the blue line represents BiDil and the orange line represents placebo. The plot also includes statistics indicating a P-value of <0.001 from a log-rank test.*
The text appears to show a figure or table (Figure 4) that displays the results of demographic, baseline medication and clinical characteristic subgroups in Black Patients (A-HeFT) for all-cause mortality and first hospitalization for heart failure. The table includes percentages and relative risks with confidence intervals for each subgroup.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.